SEC Filing Update: #AVTX Avalo Therapeutics, Inc. : $7.75

Sector: Healthcare | YTD: 🔽 -54.36% The SEC disclosed Today (13-NOV-2026) that FARALLON CAPITAL MANAGEMENT LLC has INCREASED #AVTX Shares by 59.09% 🟢 * Previous Holdings: 2.50M Shares * Current Holdings: 3.97M Shares * Increase+1.48M * Increased(%)+59.09% * Ownership: 7.4% * Estimated Investment Value: $10.86M https://www.thinksabio.com/reports/isr/AVTX Institutional ownership in #AVTX has been steadily rising over the past 5 quarters in Shares: Q2 2025: 7.84M Q3 2025: 15.32M Q4 2025: 19.89M Q1 2026: 31.10M Q2 2026: 65.75M 📌 Institutional activity in the last 30 days for #AVTX: • Trails Edge Capital Partners, LP – Increased holdings by 1,911,880 shares (29-OCT-2026) 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2121240737127821527